Article Details

GLP-1 Agonists May Reduce Risk of AF Recurrence Postablation in Patients With Type 2 DM

Retrieved on: 2024-06-14 13:00:09

Tags for this article:

Click the tags to see associated articles and topics

GLP-1 Agonists May Reduce Risk of AF Recurrence Postablation in Patients With Type 2 DM. View article details on hiswai:

Excerpt

Glucagon-like peptide-1 receptor (GLP-1) agonist use is associated with a decreased risk for atrial fibrillation (AF) recurrence after ablation ...

Article found on: www.thecardiologyadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up